organized by MERCK SERONO International SA

16:00 - 18:30  Symposium 2    Room H1

This Workshop will continue the series of highly interactive and fun workshops held in Krakow, Rome and Adelaide aimed at further developing a framework to allow improved collaboration between HTA Agencies, health technology producers (Industry), clinicians and patients. The 2006 workshop examined the Value of Innovation and this year the focus will be on the Value of Collaboration. How to incorporate different stakeholder’s perception of appropriate evidence is an important issue in HTA and the workshop would aim to clearly identify the goals of several individual stakeholder groups in such collaborative working and to continue to identify ways forward in the development of clear and transparent practical relationships. Please see the workshop programme for more details and do please come prepared to participate!

Chair: Chris Henshall, Pro-Vice Chancellor, University of York, U.K.

16:00 to 16:05      Brief overview of previous workshops  
Andrea Rappagliosi, VP Health Policy & Government Relations Europe, Merck Serono International S.A., Switzerland

16:05 to 16:10      Goals of the Session
Andrea Rappagliosi, VP Health Policy & Government Relations Europe, Merck Serono International S.A., Switzerland

16:10 to 16:25      Value Framework / Survey
Dev Menon, Professor of Public Health Sciences, University of Alberta, Canada 

16:25 to 16:40     Audience Discussion: « Values »    
Alan Jones, Managing Consultant, AJC Healthcare, U.K.

16:40 to 16.55      Devices case study: “Effect of communication between company and HTA Agency”  
Brigitte Casteels, VP International Health Policy & Government Relations, Kyphon International, Switzerland

16:55 to 17.10      EMEA: providing scientific and protocol advice 
David Lyons, Member, EMEA Scientific Committees, CHMP and COMP

17:10 to 17.30      Audience Discussion: “Improving collaboration”  
Alan Jones, Managing Consultant, AJC Healthcare, U.K.

17:30 to 17.40    Summary        
Chris Henshall, Pro-Vice Chancellor, University of York, U.K. 

17.40 to 18.00  Stakeholder Presentations    
Alan Jones (Chair)

HTA Agency  
François Meyer, Director, Haute Autorité de Santé, France    

Academia  
Rod Taylor, PENTAG, Dept. Public Health & Epidemiology, Univ. of Exeter & Plymouth, U.K.

Industry 
Penny Albright, VP Government & Health Economics, Janssen-Ortho Inc., Canada

Patients  
Alastair Kent, Director, GIG, U.K.

Spanish Policy Makers
Ramon Maspons, Director Research Plan, Catalan Ministry of Health, Spain

18.00 to 18.20  Audience Discussion: « Values »    
Alan Jones, Managing Consultant, AJC Healthcare, U.K.

18.20 to 18.30  Wrap-Up and Next Steps on Discussion Paper     
Chris Henshall, Pro-Vice Chancellor, University of York, U.K.